Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity

BACKGROUND: To date, no safe allergen-specific immunotherapy for patients with peanut allergy is available. Previous trials were associated with severe side effects. OBJECTIVE: We sought to determine the relative importance of conformational and linear IgE-binding epitopes of the major peanut allerg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Allergy Clin Immunol
Main Authors: Tscheppe, Angelika, Palmberger, Dieter, van Rijt, Leonie, Kalic, Tanja, Mayr, Vanessa, Palladino, Chiara, Kitzmüller, Claudia, Hemmer, Wolfgang, Hafner, Christine, Bublin, Merima, van Ree, Ronald, Grabherr, Reingard, Radauer, Christian, Breiteneder, Heimo
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7100897/
https://ncbi.nlm.nih.gov/pubmed/31525384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2019.08.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados